David A. Matthews

Department for Work and Pensions — United Kingdom

Medicine · Health Sciences

64h-index16.5kcitations273works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(59), Viral gastroenteritis research and epidemiology(39), Virus-based gene therapy research(38), Animal Virus Infections Studies(37), interferon and immune responses(28)

Publications272 total

Discontinuous EBOV RNA synthesis events in patients with Ebola virus disease and their relationship to viral load and outcome of infection
Journal of Virology·2025· 1 citedOpen Access
Identification of a novel structural motif and overexpression of key transcripts elucidated in Adenovirus 10
2025Open Access
A direct RNA-seq-based EBV latency transcriptome offers insights into the biogenesis of EBV gene products
Journal of General Virology·2025· 3 citedOpen Access
Hypoxia inducible factors regulate Pneumovirus replication by enhancing innate immune sensing
2025Open Access
SARS-CoV-2 infection enhancement by amphotericin B: implications for disease management
Journal of Virology·2025· 2 citedOpen Access
Are groundbreaking science discoveries becoming harder to find?
Nature·2025· 4 citedOpen Access
A Novel Toolkit of SARS-CoV-2 Sub-Genomic Replicons for Efficient Antiviral Screening
Viruses·2025· 1 citedOpen Access
A direct RNA-seq-based EBV Latency Transcriptome Offers Insights into the Biogenesis of EBV Gene Products
2025Open Access
Examining the feasibility of replacing ORF3a with fluorescent genes to construct SARS-CoV-2 reporter viruses
Journal of General Virology·2025· 1 citedOpen Access
Using minor variant genomes and machine learning to study the genome biology of SARS-CoV-2 over time
Nucleic Acids Research·2025· 2 citedOpen Access
SARS-CoV-2 infection enhancement by Amphotericin B: Implications for disease management
2024Open Access
1556P Current landscape of drug approvals for genitourinary (GU) cancers in North America and Europe
Annals of Oncology·2024
Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19
Viruses·2024· 18 citedOpen Access
Hypoxia inducible factors inhibit respiratory syncytial virus infection by modulation of nucleolin expression
iScience·2023· 15 citedOpen Access
SARS-CoV-2 NSP12 associates with TRiC and the P323L substitution acts as a host adaption
Journal of Virology·2023· 8 citedOpen Access
Hypoxia inducible factors inhibit respiratory syncytial virus infection by modulation of nucleolin expression
2023· 1 citedOpen Access
The SARS-CoV-2 protein ORF3c is a mitochondrial modulator of innate immunity
iScience·2023· 26 citedOpen Access
Predicting the past and future evolutionary space of SARS-CoV-2
2023Open Access
Recombinant SARS-CoV-2 lacking initiating and internal methionine codons within ORF10 is attenuated <i>in vivo</i>
2023· 2 citedOpen Access
SARS CoV 2 ORF10KO paper raw data
Zenodo (CERN European Organization for Nuclear Research)·2023Open Access
page 1 of 14Next →

Frequent Co-authors

Rose Ann Ferre(11), Amy K. Patick(11), James W. Meador(11), Julian A. Hiscox(10), Stephen T. Worland(10), Shella A. Fuhrman(10), J. Kraut(9), Edward L. Brown(9), Peter S. Dragovich(8), Thomas J. Prins(8), Ru Zhou(8), Susan L. Binford(7), Maia Kavanagh Williamson(6), Andrew D. Davidson(6), L S Zalman(6), J.T. Bolin(5), David J. Filman(5), Miles W. Carroll(5), Kate J. Heesom(5), Thomas F. Hendrickson(5)